SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.

Quotes for SelectImmune Pharma AB (publ)

Right Now

+/-
-0.04
%
-0,76%
Latest
5.2
High
5.2
Low
5.2
Volume
10
Turnover (SEK)
52
Market Value (MSEK)
90,8
Time (Latest trade)

Board

CEO

  • Gabriela Godaly (tf)

Chairperson of the Board

  • Catharina Svanborg

Board

  • Carl-Johan Wachtmeister
  • Gabriela Godaly
  • Helena Lomberg

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 45,84 73,33 2022-06-28
Rolf Karlsson 6,42 3,16 2022-06-28
Fredrik Herslow 5,05 2,18 2019-06-26
Avanza Pension 3,43 1,69 2022-06-28
Jan Zetterberg 3,24 1,60 2022-06-28
Björn Wullt 1,83 0,79 2019-06-26
Swedbank Försäkring 1,76 0,87 2022-06-28
Helena Lomberg 1,46 0,72 2022-06-28
Nordnet Pensionsförsäkring 1,42 0,70 2022-06-28
Understödsföreningen Prometheus Pension 1,22 0,53 2019-06-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-11-16 Delårsrapport 2023-Q1

  • 2022-11-23 Årsstämma 2022